Conversely, because AFP levels in blood are high in only approximately 60% of liver cancer patients and other benign diseases (hepatitis, liver cirrhosis), there is a limitation in using AFP alone as an HCC marker in blood [40], [41], [42], [43], [44], [45], [46], [47], [48]. The gene discussed is AFP; the disease is liver cancer.